Most Clicked StoriesMore >


One person dies, 5 hospitalized in clinical trial of pain drug

American Pain Society SmartBrief | Jan 20, 2016

A clinical trial participant in France died and five others were hospitalized after taking an investigative pain drug developed by Portuguese drugmaker Bial. The study included 90 healthy volunteers who were given varied doses, and the company said 108 study participants had taken the drug without moderate or serious reactions before the trial began. The New York Times (free-article access for SmartBrief readers) (01/17)


Study: Brain, immune system changes seen with chronic pain

American Pain Society SmartBrief | Feb 03, 2016

Group releases guideline for opioid use disorder treatment

American Pain Society SmartBrief | Jan 27, 2016

Study finds distinct fibromyalgia subclusters

American Pain Society SmartBrief | Jan 27, 2016

Expert panel to report on proposed opioid prescribing guidelines

American Pain Society SmartBrief | Jan 20, 2016

Study: Guideline cuts opioid prescribing in acute care setting

American Pain Society SmartBrief | Feb 03, 2016

Migraine patients report fewer headaches using medical marijuana

American Pain Society SmartBrief | Jan 20, 2016

Researchers find pressure points, triggers for fibromyalgia

American Pain Society SmartBrief | Feb 03, 2016

Study: Distraction may not help children during needle pricks

American Pain Society SmartBrief | Feb 10, 2016

MRI offers insights into pain drug research

American Pain Society SmartBrief | Feb 10, 2016


Find American Pain Society SmartBrief Issues by Date:





Sign up for American Pain Society SmartBrief



Designed specifically for the pain professional, the APS SmartBrief is a FREE, weekly e-mail newsletter. By providing the latest need-to-know industry news and information, APS SmartBrief saves you time and keeps you smart. Learn more